TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4526895
log Bayes Factor = 0.06979
Chromosome 13   position 39,350,890  (GRCh37) Explore rs4526895 on Ensembl!
Variant rs4526895 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.245 0.755 0.000
C91 Lymphoid leukaemia
0.242 0.757 0.000
C91.1 Chronic lymphocytic leukaemia
0.239 0.761 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.235 0.765 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.232 0.768 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.226 0.774 0.000
C90.2 Plasmacytoma, extramedullary
0.218 0.782 0.000
C83.3 Large cell (diffuse)
0.216 0.784 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.199 0.801 0.000
C81 Hodgkin's disease
0.199 0.801 0.000
C90.0 Multiple myeloma
0.197 0.803 0.000
C91.9 Lymphoid leukaemia, unspecified
0.196 0.804 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.196 0.804 0.000
C91.5 Adult T-cell leukaemia
0.192 0.808 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.192 0.808 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.186 0.814 0.000
C92 Myeloid leukaemia
0.185 0.815 0.000
C83.1 Small cleaved cell (diffuse)
0.185 0.815 0.000
C93 Monocytic leukaemia
0.183 0.817 0.000
C85.1 B-cell lymphoma, unspecified
0.182 0.818 0.000
C91.4 Hairy-cell leukaemia
0.178 0.822 0.000
C90.3 Solitary plasmacytoma
0.177 0.823 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.176 0.824 0.000
C94 Other leukaemias of specified cell type
0.176 0.824 0.000
C86 Other specified types of T/NK-cell lymphoma
0.176 0.824 0.000
C90.1 Plasma cell leukaemia
0.175 0.824 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.174 0.826 0.000
C91.7 Other lymphoid leukaemia
0.174 0.826 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.174 0.826 0.000
C91.3 Prolymphocytic leukaemia
0.174 0.826 0.000
C91.2 Subacute lymphocytic leukaemia
0.174 0.826 0.000
C83.7 Burkitt's tumour
0.171 0.829 0.000
C88 Malignant immunoproliferative diseases
0.167 0.832 0.000
C83.6 Undifferentiated (diffuse)
0.167 0.833 0.000
C83.5 Lymphoblastic (diffuse)
0.167 0.833 0.000
C83.4 Immunoblastic (diffuse)
0.167 0.833 0.000
C83.2 Mixed small and large cell (diffuse)
0.167 0.833 0.000
C82.4 Follicular lymphoma grade IIIb
0.165 0.835 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.163 0.837 0.000
C85.0 Lymphosarcoma
0.162 0.837 0.000
C83.0 Small cell (diffuse)
0.162 0.838 0.000
C82.2 Large cell, follicular
0.161 0.839 0.000
C95 Leukaemia of unspecified cell type
0.161 0.839 0.000
C92.9 Myeloid leukaemia, unspecified
0.160 0.840 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.159 0.841 0.000
C81.7 Other Hodgkin's disease
0.156 0.843 0.000
C82.3 Follicular lymphoma grade IIIa
0.149 0.850 0.000
C81.9 Hodgkin's disease, unspecified
0.149 0.851 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.149 0.851 0.000
C81.1 Nodular sclerosis
0.149 0.851 0.000
C91.0 Acute lymphoblastic leukaemia
0.147 0.853 0.000
C82.6 Cutaneous follicle centre lymphoma
0.143 0.857 0.000
C82.5 Diffuse follicle centre lymphoma
0.143 0.857 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.143 0.857 0.000
C81.3 Lymphocytic depletion
0.143 0.857 0.000
C81.2 Mixed cellularity
0.143 0.857 0.000
C81.0 Lymphocytic predominance
0.143 0.857 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.140 0.860 0.000
C93.1 Chronic monocytic leukaemia
0.139 0.861 0.000
C92.7 Other myeloid leukaemia
0.139 0.861 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.133 0.867 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.133 0.867 0.000
C92.5 Acute myelomonocytic leukaemia
0.133 0.867 0.000
C92.4 Acute promyelocytic leukaemia
0.133 0.867 0.000
C92.3 Myeloid sarcoma
0.133 0.867 0.000
C92.2 Subacute myeloid leukaemia
0.133 0.867 0.000
C93.9 Monocytic leukaemia, unspecified
0.131 0.868 0.000
C93.7 Other monocytic leukaemia
0.131 0.868 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.131 0.868 0.000
C93.2 Subacute monocytic leukaemia
0.131 0.868 0.000
C93.0 Acute monocytic leukaemia
0.131 0.868 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.129 0.870 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.126 0.874 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.126 0.874 0.000
C86.4 Blastic NK-cell lymphoma
0.126 0.874 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.126 0.874 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.126 0.874 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.126 0.874 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.126 0.874 0.000
C94.7 Other specified leukaemias
0.126 0.874 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.126 0.874 0.000
C94.5 Acute myelofibrosis
0.126 0.874 0.000
C94.4 Acute panmyelosis
0.126 0.874 0.000
C94.3 Mast cell leukaemia
0.126 0.874 0.000
C94.2 Acute megakaryoblastic leukaemia
0.126 0.874 0.000
C94.1 Chronic erythraemia
0.126 0.874 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.126 0.874 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.126 0.874 0.000
C96.8 Histiocytic sarcoma
0.126 0.874 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.126 0.874 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.126 0.874 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.126 0.874 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.126 0.874 0.000
C96.3 True histiocytic lymphoma
0.126 0.874 0.000
C96.2 Malignant mast cell tumour
0.126 0.874 0.000
C96.1 Malignant histiocytosis
0.126 0.874 0.000
C96.0 Letterer-Siwe disease
0.126 0.874 0.000
C92.0 Acute myeloid leukaemia
0.125 0.875 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.124 0.876 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.120 0.880 0.000
C88.7 Other malignant immunoproliferative diseases
0.120 0.880 0.000
C88.3 Immunoproliferative small intestinal disease
0.120 0.880 0.000
C88.2 Gamma heavy chain disease
0.120 0.880 0.000
C88.1 Alpha heavy chain disease
0.120 0.880 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.117 0.883 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.116 0.884 0.000
C95.7 Other leukaemia of unspecified cell type
0.116 0.884 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.116 0.884 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.116 0.884 0.000
C95.0 Acute leukaemia of unspecified cell type
0.116 0.884 0.000
C82.0 Small cleaved cell, follicular
0.111 0.888 0.000
C95.9 Leukaemia, unspecified
0.101 0.899 0.000
C92.1 Chronic myeloid leukaemia
0.101 0.899 0.000
C84.5 Other and unspecified T-cell lymphomas
0.095 0.904 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.093 0.907 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.093 0.907 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.093 0.907 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.093 0.907 0.000
C84.3 Lymphoepithelioid lymphoma
0.093 0.907 0.000
C84.2 T-zone lymphoma
0.093 0.907 0.000
C84.1 Sezary's diease
0.093 0.907 0.000
C84.0 Mycosis fungoides
0.087 0.913 0.000
C84.4 Peripheral T-cell lymphoma
0.052 0.947 0.001
N86 Erosion and ectropion of cervix uteri
0.044 0.956 0.000
L57.0 Actinic keratosis
0.041 0.959 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.035 0.965 0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.032 0.968 0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.029 0.971 0.000
L57.4 Cutis laxa senilis
0.027 0.973 0.000
L57.5 Actinic granuloma
0.025 0.974 0.000
L57.3 Poikiloderma of Civatte
0.025 0.974 0.000
L57.2 Cutis rhomboidalis nuchae
0.025 0.974 0.000
L57.1 Actinic reticuloid
0.025 0.974 0.000
T39.1 4-Aminophenol derivatives
0.000 0.983 0.017
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.983 0.017
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.983 0.017
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.984 0.016
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.985 0.015
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.015 0.985 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.985 0.014
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.986 0.014
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.986 0.014
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.986 0.014
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.986 0.014
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.987 0.013
T39.0 Salicylates
0.000 0.987 0.013
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.988 0.012
T43.9 Psychotropic drug, unspecified
0.000 0.988 0.012
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.988 0.012
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.988 0.012
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.012 0.988 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.988 0.012
T39.4 Antirheumatics, not elsewhere classified
0.000 0.988 0.012
T39.2 Pyrazolone derivatives
0.000 0.988 0.012
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.988 0.012
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.989 0.011
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.989 0.011
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.989 0.011
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.989 0.011
T40.2 Other opioids
0.000 0.989 0.011
L58 Radiodermatitis
0.011 0.989 0.000
L55 Sunburn
0.011 0.989 0.000
T36 Poisoning by systemic antibiotics
0.000 0.989 0.011
T40.6 Other and unspecified narcotics
0.000 0.989 0.011
T45.5 Anticoagulants
0.000 0.989 0.011
T40.4 Other synthetic narcotics
0.000 0.989 0.011
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.989 0.011
T43.2 Other and unspecified antidepressants
0.000 0.989 0.011
T38.1 Thyroid hormones and substitutes
0.000 0.989 0.011
T38.9 Other and unspecified hormone antagonists
0.000 0.989 0.010
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.989 0.010
T38.7 Androgens and anabolic congeners
0.000 0.989 0.010
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.989 0.010
T38.5 Other oestrogens and progestogens
0.000 0.989 0.010
T38.4 Oral contraceptives
0.000 0.989 0.010
T38.2 Antithyroid drugs
0.000 0.989 0.010
T38.0 Glucocorticoids and synthetic analogues
0.000 0.989 0.010
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.989 0.011
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.989 0.011
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.989 0.010
L56 Other acute skin changes due to ultraviolet radiation
0.010 0.990 0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation
0.010 0.990 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.990 0.010
T40.8 Lysergide [LSD]
0.000 0.990 0.010
T40.7 Cannabis (derivatives)
0.000 0.990 0.010
T40.5 Cocaine
0.000 0.990 0.010
T40.3 Methadone
0.000 0.990 0.010
T40.1 Heroin
0.000 0.990 0.010
T40.0 Opium
0.000 0.990 0.010
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.990 0.010
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.990 0.009
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.991 0.009
T45.8 Other primarily systemic and haematological agents
0.000 0.991 0.009
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.991 0.009
T45.6 Fibrinolysis-affecting drugs
0.000 0.991 0.009
T45.4 Iron and its compounds
0.000 0.991 0.009
T45.3 Enzymes, not elsewhere classified
0.000 0.991 0.009
T45.2 Vitamins, not elsewhere classified
0.000 0.991 0.009
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified
0.009 0.991 0.000
L59.0 Erythema ab igne [dermatitis ab igne]
0.009 0.991 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.991 0.009
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.992 0.008
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.992 0.008
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.992 0.008
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.992 0.008
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.992 0.008
T44.0 Anticholinesterase agents
0.000 0.992 0.008
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.992 0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.992 0.008
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.992 0.008
T41.5 Therapeutic gases
0.000 0.992 0.008
T41.4 Anaesthetic, unspecified
0.000 0.992 0.008
T41.3 Local anaesthetics
0.000 0.992 0.008
T41.2 Other and unspecified general anaesthetics
0.000 0.992 0.008
T41.1 Intravenous anaesthetics
0.000 0.992 0.008
T41.0 Inhaled anaesthetics
0.000 0.992 0.008
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.992 0.008
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.992 0.008
T48.5 Anti-common-cold drugs
0.000 0.992 0.008
T48.4 Expectorants
0.000 0.992 0.008
T48.3 Antitussives
0.000 0.992 0.008
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.992 0.008
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.992 0.008
T48.0 Oxytocic drugs
0.000 0.992 0.008
T49.9 Topical agent, unspecified
0.000 0.992 0.008
T49.8 Other topical agents
0.000 0.992 0.008
T49.7 Dental drugs, topically applied
0.000 0.992 0.008
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.992 0.008
T49.5 Ophthalmological drugs and preparations
0.000 0.992 0.008
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.992 0.008
T49.3 Emollients, demulcents and protectants
0.000 0.992 0.008
T49.2 Local astringents and local detergents
0.000 0.992 0.008
T49.1 Antipruritics
0.000 0.992 0.008
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.992 0.008
L55.9 Sunburn, unspecified
0.008 0.992 0.000
L55.8 Other sunburn
0.008 0.992 0.000
L55.2 Sunburn of third degree
0.008 0.992 0.000
L55.1 Sunburn of second degree
0.008 0.992 0.000
L55.0 Sunburn of first degree
0.008 0.992 0.000
L58.9 Radiodermatitis, unspecified
0.008 0.992 0.000
L58.1 Chronic radiodermatitis
0.008 0.992 0.000
L58.0 Acute radiodermatitis
0.008 0.992 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.992 0.008
T36.8 Other systemic antibiotics
0.000 0.992 0.008
T36.7 Antifungal antibiotics, systemically used
0.000 0.992 0.008
T36.6 Rifamycins
0.000 0.992 0.008
T36.5 Aminoglycosides
0.000 0.992 0.008
T36.4 Tetracyclines
0.000 0.992 0.008
T36.3 Macrolides
0.000 0.992 0.008
T36.2 Chloramphenicol group
0.000 0.992 0.008
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.992 0.008
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.992 0.008
T36.0 Penicillins
0.000 0.992 0.008
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.992 0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.992 0.008
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.992 0.008
T46.7 Peripheral vasodilators
0.000 0.992 0.008
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.992 0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.992 0.008
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.992 0.008
T37.5 Antiviral drugs
0.000 0.992 0.008
T37.4 Anthelminthics
0.000 0.992 0.008
T37.3 Other antiprotozoal drugs
0.000 0.992 0.008
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.992 0.008
T37.1 Antimycobacterial drugs
0.000 0.992 0.008
T37.0 Sulphonamides
0.000 0.992 0.008
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.992 0.008
L56.4 Polymorphous light eruption
0.007 0.992 0.000
L56.3 Solar urticaria
0.007 0.992 0.000
L56.2 Photocontact dermatitis [berloque dermatitis]
0.007 0.992 0.000
L56.1 Drug photoallergic response
0.007 0.992 0.000
L56.0 Drug phototoxic response
0.007 0.992 0.000
T42.0 Hydantoin derivatives
0.000 0.992 0.007
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.993 0.007
T46.1 Calcium-channel blockers
0.000 0.993 0.007
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.993 0.007
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.993 0.007
T42.3 Barbiturates
0.000 0.993 0.007
T42.2 Succinimides and oxazolidinediones
0.000 0.993 0.007
T42.1 Iminostilbenes
0.000 0.993 0.007
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.993 0.007
L56.8 Other specified acute skin changes due to ultraviolet radiation
0.007 0.993 0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.007 0.993 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.993 0.007
T45.0 Antiallergic and antiemetic drugs
0.000 0.993 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.994 0.006
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.994 0.006
T47.7 Emetics
0.000 0.994 0.006
T47.6 Antidiarrhoeal drugs
0.000 0.994 0.006
T47.5 Digestants
0.000 0.994 0.006
T47.3 Saline and osmotic laxatives
0.000 0.994 0.006
T47.2 Stimulant laxatives
0.000 0.994 0.006
T47.0 Histamine H(2)-receptor antagonists
0.000 0.994 0.006
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.994 0.006
M45.X9 Ankylosing spondylitis (Site unspecified)
0.006 0.994 0.000
N94.6 Dysmenorrhoea, unspecified
0.000 0.994 0.006
X62.9 Unspecified place
0.000 0.994 0.006
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.995 0.005
M88.90 Paget's disease of bone, unspecified (Multiple sites)
0.000 0.995 0.005
T50.7 Analeptics and opioid receptor antagonists
0.000 0.995 0.005
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.995 0.005
T50.5 Appetite depressants
0.000 0.995 0.005
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.995 0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.995 0.005
T50.1 Loop [high-ceiling] diuretics
0.000 0.995 0.005
T50.0 Mineralocorticoids and their antagonists
0.000 0.995 0.005
I95.1 Orthostatic hypotension
0.000 0.995 0.005
M45 Ankylosing spondylitis
0.005 0.995 0.000
T47.4 Other laxatives
0.001 0.995 0.004
T50.8 Diagnostic agents
0.000 0.995 0.005
I51.9 Heart disease, unspecified
0.000 0.995 0.005
M45.X2 Ankylosing spondylitis (Cervical region)
0.005 0.995 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.995 0.004
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.005 0.995 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.004 0.996 0.000
Z88.2 Personal history of allergy to sulphonamides
0.004 0.996 0.000
R45.8 Other symptoms and signs involving emotional state
0.000 0.996 0.004
H25.0 Senile incipient cataract
0.004 0.996 0.000
T42.4 Benzodiazepines
0.000 0.996 0.004
M80.98 Unspecified osteoporosis with pathological fracture (Other)
0.004 0.996 0.000
M80.9 Unspecified osteoporosis with pathological fracture
0.004 0.996 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.004 0.996 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.004 0.996 0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.004 0.996 0.000
M45.X4 Ankylosing spondylitis (Thoracic region)
0.004 0.996 0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.004 0.996 0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.004 0.996 0.000
I51 Complications and ill-defined descriptions of heart disease
0.000 0.996 0.004
M88.9 Paget's disease of bone, unspecified
0.000 0.996 0.003
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.997 0.003
I51.0 Cardiac septal defect, acquired
0.000 0.997 0.003
I51.3 Intracardiac thrombosis, not elsewhere classified
0.000 0.997 0.003
I51.7 Cardiomegaly
0.000 0.997 0.003
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)
0.003 0.997 0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)
0.003 0.997 0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)
0.003 0.997 0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)
0.003 0.997 0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)
0.003 0.997 0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)
0.003 0.997 0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)
0.003 0.997 0.000
R59.9 Enlarged lymph nodes, unspecified
0.000 0.997 0.003
I51.4 Myocarditis, unspecified
0.000 0.997 0.003
I51.6 Cardiovascular disease, unspecified
0.000 0.997 0.003
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)
0.000 0.997 0.003
I51.8 Other ill-defined heart diseases
0.000 0.997 0.003
M88.99 Paget's disease of bone, unspecified (Site unspecified)
0.000 0.997 0.003
I51.2 Rupture of papillary muscle, not elsewhere classified
0.000 0.997 0.003
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)
0.003 0.997 0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified
0.000 0.997 0.003
S82.10 Fracture of upper end of tibia (closed)
0.000 0.997 0.003
T90.2 Sequelae of fracture of skull and facial bones
0.003 0.997 0.000
M88.98 Paget's disease of bone, unspecified (Other)
0.000 0.997 0.003
M88.97 Paget's disease of bone, unspecified (Ankle and foot)
0.000 0.997 0.003
M88.96 Paget's disease of bone, unspecified (Lower leg)
0.000 0.997 0.003
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
M88.94 Paget's disease of bone, unspecified (Hand)
0.000 0.997 0.003
M88.93 Paget's disease of bone, unspecified (Forearm)
0.000 0.997 0.003
M88.92 Paget's disease of bone, unspecified (Upper arm)
0.000 0.997 0.003
M88.91 Paget's disease of bone, unspecified (Shoulder region)
0.000 0.997 0.003
X62.0 Home
0.000 0.997 0.003
X62.8 Other specified place
0.000 0.997 0.003
X62.7 Farm
0.000 0.997 0.003
X62.6 Industrial and construction area
0.000 0.997 0.003
X62.5 Trade and service area
0.000 0.997 0.003
X62.4 Street and highway
0.000 0.997 0.003
X62.3 Sports and athletics area
0.000 0.997 0.003
X62.2 School, other institution and public administrative area
0.000 0.997 0.003
X62.1 Residential institution
0.000 0.997 0.003
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.000 0.997 0.003
M23.30 Other meniscus derangements (Multiple sites)
0.000 0.997 0.003
S06.20 Diffuse brain injury (without open intracranial wound)
0.003 0.997 0.000
H70.9 Mastoiditis, unspecified
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.002
I51.5 Myocardial degeneration
0.000 0.997 0.002
R45.0 Nervousness
0.000 0.997 0.002
T90.9 Sequelae of unspecified injury of head
0.003 0.997 0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)
0.003 0.997 0.000
M23.34 Other meniscus derangements (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.000 0.998 0.002
M23.3 Other meniscus derangements
0.000 0.998 0.002
M80.5 Idiopathic osteoporosis with pathological fracture
0.002 0.998 0.000
O47.1 False labour at or after 37 completed weeks of gestation
0.000 0.998 0.002
R45 Symptoms and signs involving emotional state
0.000 0.998 0.002
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)
0.002 0.998 0.000
M80 Osteoporosis with pathological fracture
0.002 0.998 0.000
Z39.0 Care and examination immediately after delivery
0.000 0.998 0.002
K50.8 Other Crohn's disease
0.002 0.998 0.000
Q38.7 Pharyngeal pouch
0.002 0.998 0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity
0.000 0.998 0.002
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)
0.002 0.998 0.000
S72.00 Fracture of neck of femur (closed)
0.000 0.998 0.002
T90 Sequelae of injuries of head
0.002 0.998 0.000
R45.2 Unhappiness
0.000 0.998 0.002
T93.9 Sequelae of unspecified injury of lower limb
0.002 0.998 0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)
0.000 0.998 0.002
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.000 0.998 0.002
M23.37 Other meniscus derangements-Capsular lig
0.000 0.998 0.002
I80.9 Phlebitis and thrombophlebitis of unspecified site
0.002 0.998 0.000
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)
0.002 0.998 0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)
0.002 0.998 0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)
0.002 0.998 0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)
0.002 0.998 0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)
0.002 0.998 0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)
0.002 0.998 0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)
0.002 0.998 0.000
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)
0.002 0.998 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.002 0.998 0.000
R45.7 State of emotional shock and stress, unspecified
0.000 0.998 0.002
R45.6 Physical violence
0.000 0.998 0.002
R45.3 Demoralisation and apathy
0.000 0.998 0.002
T90.8 Sequelae of other specified injuries of head
0.002 0.998 0.000
T90.0 Sequelae of superficial injury of head
0.002 0.998 0.000
R45.5 Hostility
0.000 0.998 0.002
M80.4 Drug-induced osteoporosis with pathological fracture
0.002 0.998 0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture
0.002 0.998 0.000
M80.2 Osteoporosis of disuse with pathological fracture
0.002 0.998 0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture
0.002 0.998 0.000
C45.9 Mesothelioma, unspecified
0.000 0.998 0.002
M80.8 Other osteoporosis with pathological fracture
0.002 0.998 0.000
G30.9 Alzheimer's disease, unspecified
0.002 0.998 0.000
S06.2 Diffuse brain injury
0.002 0.998 0.000
S22.30 Fracture of rib (closed)
0.000 0.998 0.002
R23.2 Flushing
0.000 0.998 0.002
L73.9 Follicular disorder, unspecified
0.002 0.998 0.000
L73.8 Other specified follicular disorders
0.002 0.998 0.000
I95 Hypotension
0.000 0.998 0.002
G71.0 Muscular dystrophy
0.002 0.998 0.000
T90.3 Sequelae of injury of cranial nerves
0.002 0.998 0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)
0.000 0.998 0.002
C45.0 Mesothelioma of pleura
0.000 0.998 0.002
N61 Inflammatory disorders of breast
0.002 0.998 0.000
M88 Paget's disease of bone [osteitis deformans]
0.000 0.998 0.002
T90.1 Sequelae of open wound of head
0.002 0.998 0.000
C45 Mesothelioma
0.000 0.998 0.002
C49.2 Connective and soft tissue of lower limb, including hip
0.000 0.998 0.002
I98.2 Oesophageal varices in diseases classified elsewhere
0.000 0.998 0.002
M80.0 Postmenopausal osteoporosis with pathological fracture
0.002 0.998 0.000
N30.9 Cystitis, unspecified
0.002 0.998 0.000
R45.4 Irritability and anger
0.000 0.998 0.002
T90.5 Sequelae of intracranial injury
0.002 0.998 0.000
I99 Other and unspecified disorders of circulatory system
0.000 0.998 0.002
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)
0.001 0.998 0.000
M80.28 Osteoporosis of disuse with pathological fracture (Other)
0.001 0.998 0.000
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)
0.001 0.998 0.000
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)
0.001 0.998 0.000
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)
0.001 0.998 0.000
M80.24 Osteoporosis of disuse with pathological fracture (Hand)
0.001 0.998 0.000
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)
0.001 0.998 0.000
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)
0.001 0.998 0.000
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)
0.001 0.998 0.000
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)
0.001 0.998 0.000
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)
0.001 0.998 0.000
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)
0.001 0.998 0.000
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)
0.001 0.998 0.000
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)
0.001 0.998 0.000
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)
0.001 0.998 0.000
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)
0.001 0.998 0.000
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)
0.001 0.998 0.000
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)
0.001 0.998 0.000
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)
0.001 0.998 0.000
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)
0.001 0.998 0.000
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)
0.001 0.998 0.000
M80.48 Drug-induced osteoporosis with pathological fracture (Other)
0.001 0.998 0.000
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)
0.001 0.998 0.000
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)
0.001 0.998 0.000
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)
0.001 0.998 0.000
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)
0.001 0.998 0.000
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)
0.001 0.998 0.000
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)
0.001 0.998 0.000
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)
0.001 0.998 0.000
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)
0.001 0.998 0.000
H70.0 Acute mastoiditis
0.002 0.998 0.000
H70 Mastoiditis and related conditions
0.002 0.998 0.000
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)
0.001 0.998 0.000
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)
0.001 0.998 0.000
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)
0.001 0.998 0.000
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)
0.001 0.998 0.000
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)
0.001 0.998 0.000
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)
0.001 0.998 0.000
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)
0.001 0.998 0.000
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)
0.001 0.998 0.000
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)
0.001 0.998 0.000
H70.8 Other mastoiditis and related conditions
0.002 0.998 0.000
Z49.2 Other dialysis
0.002 0.998 0.000
X60-X84 Intentional self-harm
0.000 0.998 0.002
M80.89 Other osteoporosis with pathological fracture (Site unspecified)
0.001 0.998 0.000
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)
0.001 0.998 0.000
M80.86 Other osteoporosis with pathological fracture (Lower leg)
0.001 0.998 0.000
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)
0.001 0.998 0.000
M80.84 Other osteoporosis with pathological fracture (Hand)
0.001 0.998 0.000
M80.83 Other osteoporosis with pathological fracture (Forearm)
0.001 0.998 0.000
M80.82 Other osteoporosis with pathological fracture (Upper arm)
0.001 0.998 0.000
M80.81 Other osteoporosis with pathological fracture (Shoulder region)
0.001 0.998 0.000
M80.80 Other osteoporosis with pathological fracture (Multiple sites)
0.001 0.998 0.000
M46.46 Discitis, unspecified (Lumbar region)
0.002 0.998 0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)
0.002 0.998 0.000
R45.1 Restlessness and agitation
0.000 0.998 0.002
M45-M49 Spondylopathies
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.